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Research on the effectiveness of rehabilitation interventions is crucial for people with 
multiple sclerosis (MS), their caregivers, treatment providers and policy makers. Whilst 
there has been a steady increase in rehabilitation research activity over the past decade, 
studies have tended to focus on the evaluation of single interventions, such as supervised 
exercise programmes, and even here there are challenges1. In comparison few studies 
have evaluated the more complex packages, such as multi-disciplinary inpatient 
rehabilitation.  Further, as is typical across the rehabilitation arena, many of the studies 
undertaken have been pilot or feasibility studies which have not moved onto a definitive 
trial2. As a consequence, practice guidelines have been unable to make specific 
recommendations about the effectiveness of multi-disciplinary rehabilitation, with regard, for 
example, to MS subtypes, stages of disability or model of service delivery3,4. The recurring 
conclusion of systematic reviews, guidelines3,4 and commentaries5 is that there is a need 
for well-designed trials of rehabilitation therapies with adequate sample sizes and 
appropriate outcome measures, powered to measure change, over both the short and 
longer term. The randomised controlled trial of multi-disciplinary inpatient rehabilitation, 
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reported by Boesen et al. in this issue, addresses this call; it is large (n = 427), covers an 
important domain (quality of life) and follows up the outcomes at six months. The authors 
describe this article as being the first in a series on the study, reporting results of a broad 
range of secondary measures (including costs) in future publications. In doing so, this study 
provides an important contribution to the rehabilitation evidence base.  
 
Multi-disciplinary rehabilitation is highly complex, involving multiple processes, outcomes 
and stakeholders. A longstanding tenet is that the content of rehabilitation programmes 
should be individualised and based on an assessment of  the patient’s unique needs, which 
can vary widely both in terms of the presenting difficulties and the underlying contributory 
impairments. This is in conflict with the desire for standardisation of interventions within 
randomised controlled studies. A further consideration is the variability of the context (both 
physical and cultural) within which the intervention is delivered. The literature demonstrates 
a shared conceptual and practical framework to rehabilitation practice, based on a model of 
comprehensive care which extends beyond symptomatic treatment and emphasises 
optimising quality of life. However, no two rehabilitation centres appear to practice or deliver 
care in an identical way. The structure and funding mechanisms of a country’s health care 
system appears to have a major influence on the model of rehabilitation care provided. For 
example, in some countries such as those described in this Danish study, large highly 
specialised MS centres exist, whilst for others rehabilitation is predominately delivered 
within the community setting by non-MS specialists, or barely at all. A survey undertaken by 
the International Federation of MS Societies highlighted that of the 52 countries surveyed, 
only 36 reported the presence of hospital based multi-disciplinary teams6. Heterogeneity of 
patient, intervention and centre characteristics is therefore a reality that researchers need to 
contend with, even within the relatively controlled context of a randomised controlled trial. 
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Hence the importance of specifically describing characteristics of participants (e.g. MS type, 
co-morbidities, changes in pharmacological management), the intervention (content, dose 
and frequency) and context (staff and setting). This level of detail also enables comparison 
between studies and meta-analyses, if needed. The TiDiER Guidelines7 offer an excellent 
format for helping to achieve this. While somewhat demanding to provide, this information 
enables readers to make informed judgements about how transferrable the study results 
are to their own context. The supplementary material provided by Boesen at al. is 
welcomed as it goes some way to providing this level of detail.   
 
It has long been argued that the selection process for those admitted to inpatient 
rehabilitation is critical to its efficacy8. Although investigations regarding selection process 
have been made in other neurological conditions such as stroke, this is not yet the case for 
MS inpatient rehabilitation. This is important since notable differences exist in this selection 
process, both within and between different countries. In some units, people with MS are 
offered inpatient treatment on an annual basis, whereas in others patients are selectively 
admitted according to current need. A description of the referral criteria is not provided 
within this article, highlighting an aspect which could be addressed in future studies. It is 
acknowledged that the huge variation between patients, together with the multiplicity of 
symptoms and the way they interact, is likely to mean that clinical judgement will always 
play a major role in the selection process. However, key to enabling better targeting of 
resources is enhancing our knowledge, based on empirical evidence, regarding how, for 
whom, and in what circumstances rehabilitation works best.      
 
In order to move multi-disciplinary MS inpatient rehabilitation research further forwards it is 
now the time to ask specific questions beyond its general efficacy. We not only need to 
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know whether people benefit from a particular rehabilitation approach, but why. This is likely 
to come from a combination and integration of the most appropriate methods and a better 
understanding of underlying mechanisms. Just as people with MS benefit from joined-up 
thinking in terms of the delivery of their care, so too will MS researchers benefit from 
thinking about these complicated issues in an intelligent way that is informed by changing 
knowledge at the cellular level of pathology and disease processes, the individual level of 
experience, recovery and adaptation, and the social level of context. So while recognising 
that methodological challenges remain, it is hoped that a steady  accumulation of evidence, 
with contributions such as this study by Boesen at al., will help answer the questions posed 
to enable better outcomes for people living with MS. 
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